RxDoctor Payments Data

Robert Barrett, DO

Internal Medicine · Gainesville, GANPI 1780902411

Payments from drug & device makers

$219in general payments, 2019–2025

Across 12 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$52
  • Pfizer$22
  • Edwards Lifesciences$22
  • AbbVie$20
  • Daiichi Sankyo Inc.$20
  • Lilly USA, LLC$20
  • plus $62 from 4 others

What the payments were for

  • Food & beverage$219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$219 in reported general payments places this provider in the 40th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$223,132
Medicare patients
411
Services billed
14,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$172,263
TrulicityDulaglutide85$115,600
JardianceEmpagliflozin65$90,882
EliquisApixaban56$53,430
MounjaroTirzepatide34$48,803
JanuviaSitagliptin Phosphate48$48,277
MyrbetriqMirabegron31$31,521
LinzessLinaclotide35$21,612
Breo ElliptaFluticasone/Vilanterol22$17,081
XareltoRivaroxaban17$16,668
TradjentaLinagliptin11$15,895
JanumetSitagliptin Phos/Metformin Hcl15$14,426
FarxigaDapagliflozin Propanediol20$13,658
Levothyroxine Sodium528$5,094
Rosuvastatin Calcium427$3,784

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$20$164,403119 claims
Boehringer IngelheimJardiance, Tradjenta$17$106,77776 claims
PfizerEliquis, Paxlovid$22$54,84381 claims
AbbVieLinzess, Synthroid$20$25,14766 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →